17
Participants
Start Date
March 31, 2009
Primary Completion Date
December 31, 2011
Study Completion Date
March 31, 2012
Sorafenib dose escalation
Sorafenib dose escalation scheme: 3 first patients: 200 mg/d, if dose limiting toxicities (DLT) not reached: 3 patients at 200 mg BID, if no DLT reached: 3 patients at 400 mg bid
Geneva University Hospital (Hopitaux Universitaires de Geneve), Department of Oncology, Geneva
Collaborators (1)
Bayer
INDUSTRY
University Hospital, Geneva
OTHER